ADEF
AGN

Adams Diversified Equity Fund’s Allergan Inc AGN Stock Holding History

Adams Diversified Equity Fund’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-120,000
Closed -$25.5M – 88
2014
Q4 		$25.5M Hold
120,000
– – 1.68% 17
2014
Q3 		$21.4M Hold
120,000
– – 1.41% 23
2014
Q2 		$20.3M Hold
120,000
– – 1.36% 26
2014
Q1 		$14.9M Hold
120,000
– – 1.05% 36
2013
Q4 		$13.3M Sell
120,000
-8,000
-6% -$764K 0.94% 47
2013
Q3 		$11.6M Hold
128,000
– – 0.88% 54
2013
Q2 		$10.8M Buy
+128,000
New +$13.3M 0.86% 55

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Adams Diversified Equity Fund's AGN Position: Q1 2015 in Review

Adams Diversified Equity Fund sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 120,000 shares — an estimated $25.5M sold.

Adams Diversified Equity Fund first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $25.5M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Adams Diversified Equity Fund reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Adams Diversified Equity Fund sold 120,000 Allergan Inc shares in Q1 2015, an estimated $25.5M.
  • Adams Diversified Equity Fund first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Adams Diversified Equity Fund's Allergan Inc position peaked at $25.5M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Adams Diversified Equity Fund's 13F filing for Q1 2015, filed 8 May 2015.